Class III · Low riskOngoing Initiated Apr 9, 2024 (2 years ago)
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13)…
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Cross Contamination with Other Products
What was recalled
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
Recalling firm
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
NDC code
59148-008-13
Origin
N/A, Japan
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0467-2024
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.